Status
Conditions
Treatments
About
The objective of this study is to identify relevant signature gene networks of cardiovascular disease in endothelial cells derived from circulating endothelial progenitor cells of individuals with established cardiovascular disease (CVD).
Full description
The investigators propose to enroll CVD and healthy subjects between 30 and 60 years of age, matched for age, gender, body mass index, and medication (statin and anti-hypertensive) use. Circulating endothelial progenitor cells will be isolated from blood and cultured in vitro to differentiate into endothelial cells.
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria for CVD subjects::
• >50% stenosis of one or more coronary arteries
Inclusion Criteria for Healthy subjects:
• absence of coronary artery stenosis
Exclusion Criteria for all subjects:
0 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal